Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Operating Leases (2022 - 2025)

Exagen (XGN) has disclosed Operating Leases for 4 consecutive years, with $438000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases fell 73.68% year-over-year to $438000.0, compared with a TTM value of $438000.0 through Dec 2025, down 73.68%, and an annual FY2025 reading of $438000.0, down 73.68% over the prior year.
  • Operating Leases was $438000.0 for Q4 2025 at Exagen, down from $759000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $6.2 million in Q1 2022 and bottomed at $438000.0 in Q4 2025.
  • Average Operating Leases over 4 years is $3.0 million, with a median of $2.6 million recorded in 2023.
  • The sharpest move saw Operating Leases decreased 21.96% in 2023, then tumbled 73.68% in 2025.
  • Year by year, Operating Leases stood at $4.5 million in 2022, then tumbled by 38.57% to $2.8 million in 2023, then tumbled by 39.71% to $1.7 million in 2024, then crashed by 73.68% to $438000.0 in 2025.
  • Business Quant data shows Operating Leases for XGN at $438000.0 in Q4 2025, $759000.0 in Q3 2025, and $1.1 million in Q2 2025.